References
Gail MH (2008) Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 100:1037–1041
Hingorani AD, Shah T, Kumari M, Sofat R, Smeeth L (2010) Translating genomics into improved healthcare. BMJ 341:c5945. doi:10.1136/bmj.c5945
Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, Hirschhorn JN, Berglund G, Hedblad B, Groop L, Altshuler DM, Newton-Cheh C, Orho-Melander M (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358:1240–1249
Lango H, Palmer CN, Morris AD, Zeggini E, Hattersley AT, McCarthy MI, Frayling TM, Weedon MN (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57:3129–3135
McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339–2350
Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33–36
Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358:2796–2803
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL (2009) Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. Prostate 69:363–372
van HM, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, Oostra BA, Hofman A, Sijbrands EJ, Janssens AC (2008) Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study Diabetes 57:3122–3128
Varghese JS, Easton DF (2010) Genome-wide association studies in common cancers-what have we learnt? Curr Opin Genet Dev doi:10.1016/j.gde.2010.03.012
Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, Brinton LA, Lissowska J, Sherman ME, Chlebowski R, Kooperberg C, Jackson RD, Buckman DW, Hui P, Pfeiffer R, Jacobs KB, Thomas GD, Hoover RN, Gail MH, Chanock SJ, Hunter DJ (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362:986–993
Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, Adami HO, Hsu FC, Zhu Y, Balter K, Kader AK, Turner AR, Liu W, Bleecker ER, Meyers DA, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Gronberg H (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358:910–919
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pashayan, N., Pharoah, P. Translating genomics into improved population screening: hype or hope?. Hum Genet 130, 19–21 (2011). https://doi.org/10.1007/s00439-011-0985-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-011-0985-x